SCHEMBL2807068

SCHEMBL2807068

COC(=O)c1ccc(-c2cc(CCl)cc(OCc3ccccc3)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.51
HPGD P15428 1/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
RAB9A P51151 4/20 0.47
MAPT P10636 3/20 0.47
NPC1 O15118 2/20 0.47
BCL2L1 Q07817 1/20 0.46
MCL1 Q07820 1/20 0.46
MAOB P27338 1/20 0.46
PTPN1 P18031 2/20 0.45
EGFR P00533 1/20 0.45
NR4A1 P22736 1/20 0.45
NR4A2 P43354 1/20 0.45
NR4A3 Q92570 1/20 0.45
PKM P14618 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9343582 0.83 SMN1; SMN2 (0.65) LMNAHPGDMEN1KMT2ASMN1; SMN2
SCHEMBL3678773 0.83 MRGPRX4 (0.64) LMNAHPGDMEN1KMT2ASMN1; SMN2
SCHEMBL2806822 0.82 MEN1 (0.50) LMNAHPGDMEN1KMT2ASMN1; SMN2
SCHEMBL731203 0.82 LMNA (0.62) LMNAHPGDMEN1KMT2ASMN1; SMN2
SCHEMBL13168307 0.82 MAPT (0.51) HPGDMEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL27395439 0.79 RAB9A (0.68) LMNAMEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL978502 0.79 RAB9A (0.71) LMNAHPGDMEN1KMT2ASMN1; SMN2
SCHEMBL8900334 0.78 SMPD1 (0.60) LMNAHPGDMEN1KMT2ASMN1; SMN2
SCHEMBL183994 0.78 LMNA (0.70) LMNAHPGDMEN1KMT2ASMN1; SMN2
SCHEMBL391547 0.78 MEN1 (0.71) LMNAHPGDMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators SMITHKLINE BEECHAM CORPORATION (US) 2010-09-23 US disclosed
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators SMITHKLINE BEECHAM CORPORATION (US) 2010-09-23 US disclosed
EP-2081894-A1 1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS PPAR MODULATORS SmithKline Beecham Corporation (US) 2009-07-29 EP disclosed
WO-2008028118-A1 1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS PPAR MODULATORS SMITHKLINE BEECHAM CORPORAITON (US) 2008-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators PPARD, PPARA, PPARG LMNA 3033/4885HPGD 421/4885MEN1 4809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.